Literature DB >> 24902788

Oridonin induces NPM mutant protein translocation and apoptosis in NPM1c+ acute myeloid leukemia cells in vitro.

Fei-Fei Li1, Sha Yi2, Lu Wen2, Jing He2, Li-Jing Yang2, Jie Zhao2, Ben-Ping Zhang2, Guo-Hui Cui2, Yan Chen2.   

Abstract

AIM: Skewed cytoplasmic accumulation of NPM mutant protein (NPM1c+) is close related to leukemia pathogenesis. The aim of this study was to investigate whether oridonin, a diterpenoid isolated from the Chinese traditional medicine Rabdosia rubescens, was able to interfere with NPM1c+ protein trafficking and induce apoptosis in NPM1c+ acute myeloid leukemia cells in vitro.
METHODS: OCI-AML3 cell line harboring a NPM1 gene mutation was examined. Cell growth was detected by MTT assay. Cell apoptosis was evaluated using flow cytometry and Hoechst 33258 staining. The expression and subcellular localization of relevant proteins were detected by Western blot and immunofluorescent staining. The mRNA expression was detected by RT-PCR.
RESULTS: Oridonin (2-12 μmol/L) dose-dependently inhibited the viability of OCI-AML3 cells (the IC50 value was 3.27±0.23 μmol/L at 24 h). Moreover, oridonin induced OCI-AML3 cell apoptosis accompanied by activation of caspase-3 and nuclear translocation of NPM1c+ protein. Oridonin did not change the expression of Crm1 (the export receptor for nuclear export signal-containing proteins), but induced nuclear translocation of Crm1. Oridonin markedly increased the expression of nucleoporin98 (Nup98), which had an important role in Crm1-mediated nuclear protein export, and induced nuclear accumulation of Nup98. Furthermore, oridonin markedly increased the expression of p14arf and p53.
CONCLUSION: In NPM1c+ leukemia cells, oridonin induces NPM1c+ protein translocation into the nucleus possibly via nuclear accumulation of Crm1; the compound markedly increases p53 and p14arf expression, which may contribute to cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24902788      PMCID: PMC4086383          DOI: 10.1038/aps.2014.25

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  25 in total

1.  Nucleophosmin in acute myelogenous leukemia.

Authors:  Masao Nakagawa; Yoshihiro Kameoka; Ritsuro Suzuki
Journal:  N Engl J Med       Date:  2005-04-28       Impact factor: 91.245

2.  Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo.

Authors:  Guang-Biao Zhou; Hui Kang; Lan Wang; Li Gao; Ping Liu; Jun Xie; Feng-Xiang Zhang; Xiang-Qin Weng; Zhi-Xiang Shen; Jue Chen; Long-Jun Gu; Ming Yan; Dong-Er Zhang; Sai-Juan Chen; Zhen-Yi Wang; Zhu Chen
Journal:  Blood       Date:  2006-12-29       Impact factor: 22.113

3.  The cytoplasmic NPM mutant induces myeloproliferation in a transgenic mouse model.

Authors:  Ke Cheng; Paolo Sportoletti; Keisuke Ito; John G Clohessy; Julie Teruya-Feldstein; Jeffery L Kutok; Pier Paolo Pandolfi
Journal:  Blood       Date:  2009-08-07       Impact factor: 22.113

4.  Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway.

Authors:  He-Qi Bu; Jiang Luo; Hui Chen; Jian-Hong Zhang; Hong-Hai Li; Hong-Chun Guo; Zhao-Hong Wang; Sheng-Zhang Lin
Journal:  Int J Oncol       Date:  2012-06-14       Impact factor: 5.650

5.  Expression of the cytoplasmic NPM1 mutant (NPMc+) causes the expansion of hematopoietic cells in zebrafish.

Authors:  Niccolò Bolli; Elspeth M Payne; Clemens Grabher; Jeong-Soo Lee; Adam B Johnston; Brunangelo Falini; John P Kanki; A Thomas Look
Journal:  Blood       Date:  2010-03-02       Impact factor: 22.113

6.  Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells.

Authors:  Chuan-Xu Liu; Qian-Qian Yin; Hu-Chen Zhou; Ying-Li Wu; Jian-Xin Pu; Li Xia; Wei Liu; Xin Huang; Tao Jiang; Ming-Xuan Wu; Li-Cai He; Ya-Xue Zhao; Xiao-Lin Wang; Wei-Lie Xiao; Hong-Zhuan Chen; Qian Zhao; Ai-Wu Zhou; Li-Shun Wang; Han-Dong Sun; Guo-Qiang Chen
Journal:  Nat Chem Biol       Date:  2012-04-08       Impact factor: 15.040

7.  Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin.

Authors:  H Quentmeier; M P Martelli; W G Dirks; N Bolli; A Liso; R A F Macleod; I Nicoletti; R Mannucci; A Pucciarini; B Bigerna; M F Martelli; C Mecucci; H G Drexler; B Falini
Journal:  Leukemia       Date:  2005-10       Impact factor: 11.528

8.  Oridonin-induced apoptosis in SW620 human colorectal adenocarcinoma cells.

Authors:  Zhe Ji; Qingjiu Tang; Jinsong Zhang; Yan Yang; Yanfang Liu; Yingjie Pan
Journal:  Oncol Lett       Date:  2011-09-02       Impact factor: 2.967

Review 9.  Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.

Authors:  B Falini; N Bolli; A Liso; M P Martelli; R Mannucci; S Pileri; I Nicoletti
Journal:  Leukemia       Date:  2009-06-11       Impact factor: 11.528

10.  The mobile FG nucleoporin Nup98 is a cofactor for Crm1-dependent protein export.

Authors:  Masahiro Oka; Munehiro Asally; Yoshinari Yasuda; Yutaka Ogawa; Taro Tachibana; Yoshihiro Yoneda
Journal:  Mol Biol Cell       Date:  2010-04-07       Impact factor: 4.138

View more
  12 in total

1.  Engineering chromosome region maintenance 1 fragments that bind to nuclear export signals.

Authors:  Yuqin Lei; Qi An; Yuqing Zhang; Ping Luo; Youfu Luo; Xiaofei Shen; Da Jia; Qingxiang Sun
Journal:  Protein Sci       Date:  2019-09-14       Impact factor: 6.725

2.  Pseudolaric acid B inhibits proliferation in SW579 human thyroid squamous cell carcinoma.

Authors:  Jinghua Yu; Peiyou Ren; Ting Zhong; Yalin Wang; Minghui Yan; Bianbian Xue; Rui Li; Chunyan Dai; Chunyu Liu; Guang Chen; Xiao-Fang Yu
Journal:  Mol Med Rep       Date:  2015-10-05       Impact factor: 2.952

3.  Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway.

Authors:  Ying Lu; Yang Sun; Jianwei Zhu; Lisha Yu; Xiubo Jiang; Jie Zhang; Xiaochen Dong; Bo Ma; Qi Zhang
Journal:  Cell Death Dis       Date:  2018-01-11       Impact factor: 8.469

Review 4.  Inhibiting cancer cell hallmark features through nuclear export inhibition.

Authors:  Qingxiang Sun; Xueqin Chen; Qiao Zhou; Ezra Burstein; Shengyong Yang; Da Jia
Journal:  Signal Transduct Target Ther       Date:  2016-07-01

5.  Oridonin induces Mdm2-p60 to promote p53-mediated apoptosis and cell cycle arrest in neuroblastoma.

Authors:  Han-Qing Zhu; Chao Zhang; Zhu-Ying Guo; Jun-Mei Yang; Jia-Hui Guo; Chen Chen; Qiang-Hua Yao; Feng Liu; Quan-Wu Zhang; Feng-Hou Gao
Journal:  Cancer Med       Date:  2019-07-24       Impact factor: 4.452

Review 6.  Small Molecule Inhibitors of CRM1.

Authors:  Bibiana I Ferreira; Bastien Cautain; Inês Grenho; Wolfgang Link
Journal:  Front Pharmacol       Date:  2020-05-07       Impact factor: 5.810

7.  Oridonin ameliorates inflammation-induced bone loss in mice via suppressing DC-STAMP expression.

Authors:  Bin-Hua Zou; Yan-Hui Tan; Wen-de Deng; Jie-Huang Zheng; Qin Yang; Min-Hong Ke; Zong-Bao Ding; Xiao-Juan Li
Journal:  Acta Pharmacol Sin       Date:  2020-08-04       Impact factor: 6.150

8.  Pseudolaric acid B induced autophagy, but not apoptosis, in MRC5 human fibroblast cells.

Authors:  Yue Wang; Hongmei Gao; Ting Wu; Zengyan Wang; Fengmei Song; Antian Chen; Jing Zhang; Wenyan Zhang; Hui Zhang; Jinghua Yu
Journal:  Oncol Lett       Date:  2017-11-15       Impact factor: 2.967

9.  Conformational stabilization as a strategy to prevent nucleophosmin mislocalization in leukemia.

Authors:  María A Urbaneja; Lars Skjærven; Oscar Aubi; Jarl Underhaug; David J López; Igor Arregi; Marián Alonso-Mariño; Andoni Cuevas; José A Rodríguez; Aurora Martinez; Sonia Bañuelos
Journal:  Sci Rep       Date:  2017-10-24       Impact factor: 4.379

10.  Mechanisms of inhibiting human leukemia cell lines by serum of rats treated with compound banmao capsule.

Authors:  Li Li; Lixia Zhu; Jingjing Zhu; Xiaofen Fan; Xiujin Ye
Journal:  Oncol Lett       Date:  2017-07-28       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.